G. Vandecasteele et al., ROLE OF THE NO-CGMP PATHWAY IN THE MUSCARINIC REGULATION OF THE L-TYPE CA2+ CURRENT IN HUMAN ATRIAL MYOCYTES, Journal of physiology, 506(3), 1998, pp. 653-663
1. The whole-cell patch-clamp technique was used to examine the partic
ipation of nitric oxide synthase (NOS) and soluble guanylyl cyclase in
the muscarinic regulation of the L-type Ca2+ current (I-Ca) in freshl
y isolated human atrial myocytes. 2. Acetylcholine (ACh, 1 mu M) decre
ased basal I-Ca by 39.1 +/- 5.5% (n = 8) under control conditions, and
by 38.0 +/- 6.1.% (n = 6) in the presence of 1H-[1,2,4]oxadiazolo[4,3
-a]quinoxaline-1-one (ODQ, 10 mu M), a potent guanylyl cyclase inhibit
or, and N-G-monomethyl-L-arginine (L-NMMA, 1 mM), a competitive NOS in
hibitor. L-NMMA alone had no effect on I-Ca, whilst ODQ increased I-Ca
in 50% of the cells. 3. The accentuated antagonism of ACh on I-Ca, i.
e. its ability to antagonize the stimulatory effect of beta-adrenergic
agonists and, by extension, of other cAMP-elevating agents, was exami
ned after the current was stimulated by either the beta-adrenergic ago
nist isoprenaline (Iso) or serotonin (5-HT). ACh (100 nM or 1 mu M) co
mpletely blocked the stimulatory effects of 10 nM Iso or 10 nM 5-HT on
I-Ca. 4. Extracellular application of Methylene Blue (MBlue, 10 mu M)
, a guanylyl cyclase inhibitor, antagonized the inhibitory effect of 1
mu M ACh on Iso- or 5-HT-stimulated I-Ca. However, this effect was ov
ercome by a 100-fold higher ACh concentration and was not mimicked by
an intracellular application of MBlue. 5. Inhibition of NOS and solubl
e guanylyl cyclase activities by addition of ODQ (10 mu M) and L-NMMA
(1 mM) to both extracellular and intracellular solutions, or by a 2 h
pre-incubation of the cells with these inhibitors, modified neither th
e Iso (10 nM) response nor the inhibitory effect of ACh (100 nM or 1 m
u M) on Iso-stimulated I-Ca. 6. Extracellular application of the NO do
nor SNAP (S-nitroso-N-acetyl-D,L-penicillamine) at 100 nM produced a s
timulatory effect on I-Ca in control conditions. This stimulatory effe
ct was abolished by intracellular MBlue (20 mu M) or by intracellular
and extracellular application of ODQ (10 mu M) in combination with L-N
MMA (1 mM). 7. We conclude that the NO-cGMP pathway does not contribut
e significantly to the muscarinic regulation of I-Ca in human atrial m
yocytes.